Can anti-thrombotic new membrane improve the tendency to progression of arteriosclerosis in diabetic nephropathy dialysis patients?

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026339

Enrollment

Registered

2017-03-17

Start date

2015-02-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic renal failure

Interventions

Group1:Dialyzer was changed to new PS membrane &quot

NV&quot

. Group2:Conventional PS membrane dialyzer &quot

APS&quot

has been used.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ?Patient with maintenance hemodialysis therapy. ?Patient using APS dialyzer.

Exclusion criteria

Exclusion criteria: ?With an active infection clearly.

Design outcomes

Primary

Measure	Time frame
?Development rate of cardiovascular event	—

Secondary

Measure	Time frame
?Marker of arteriosclerosis development (Pentosidine,ELAM) ?Pressure decrease rate	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026